BOC Sciences Blog

Research and Development of Janus Kinase (JAK) Inhibitors

Introduction of JAK-STAT signaling Pathway The JAK-STAT signaling pathway is a signal transduction pathway stimulated by cytokines, which is involved in many important biological processes such as cell proliferation, differentiation, […]

FDA approved 3-4 heterocyclic oxygen drugs

FDA approved 3-4 heterocyclic oxygen drugs

Oxygen heterocyclic ring is one of the most common heterocyclic rings in drugs and natural products. By the end of 2017, 311 drug molecules had at least one oxygen heterocyclic […]

Star tumor suppressor gene p53

Introduction P53 tumor suppressor gene is a kind of gene that inhibits cells from transforming into cancer cells in living organisms. There are oncogene and tumor suppressor gene in the […]

Overview of PI3K inhibitors in research competition

PI3K is called Phosphatidylinositol 3-kinase (phosphatidylinositol 3-kinase), which is involved in the regulation of various cellular functions such as cell proliferation, differentiation, apoptosis and glucose transport. An increase in PI3K […]

Latest Clinical Trials of Lung and Liver Cancer

Latest Clinical Trials of Lung and Liver Cancer

This article takes stock of the latest clinical development pipeline for lung and liver cancer. We calculated clinical trial data for clinical phase Ⅰ, and phase Ⅱ and phase Ⅲ […]

Toll-like receptors: Roles in disease and therapy

Toll-like receptors (TLRs) are a class of proteins plays an important role in the natural immune system receptor, it was found in the 1990s, a typical pattern recognition receptor (PRR), […]

Science: Significant progress! Developed a new type of inflammatory inhibitor-small molecule OGG1 inhibitor

Inflammation Inflammation is a self-limiting, localized response to any tissue injury or trauma caused by wounding or infection, and is characterized by redness, heat, pain and swelling (rubor, calor, dolor, […]

The development of TRK inhibitors

Cancer treatment has entered the era of precision medicine, and an important feature of precision medicine is the selection of targeted drugs based on the patient’s tumor characteristics. In the […]

Research status of PD-1 and PD-L1

Announcement of the 2018 Nobel Prize in Physiology or Medicine by Professor Thomas Perlmann, Secretary of the Nobel Committee for Physiology or Medicine, on 1 October 2018. It was awarded […]

Clinical trials of the three kinds of cancer

Clinical trials of the three kinds of cancer

This article takes stock of the latest clinical development pipelines for cervical cancer, pancreatic cancer, and leukemia. We calculated clinical trial data for clinical phase Ⅰ, phase Ⅱ, and phase Ⅲ of […]